ArticleNPJ breast cancer2024

Results from the randomized KEYNOTE-355 study of pembrolizumab plus chemotherapy for Asian patients with advanced TNBC.

Seock-Ah Im et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.